Glutathione S-Transferase Ω 1 variation does not influence age at onset of Huntington's disease

BMC Medical Genetics

Volumn 5, Issue , 2004, Pages

  Arning, Larissa ^a   Jagiello, Peter ^a   Wieczorek, Stefan ^a   Saft, Carsten ^b   Andrich, Jürgen ^b   Epplen, Jörg T ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE;

5' UNTRANSLATED REGION; ALZHEIMER DISEASE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DNA POLYMORPHISM; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC TRAIT; GENOTYPE; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; ONSET AGE; PARKINSON DISEASE; PREDICTION; STATISTICAL ANALYSIS; TANDEM REPEAT;

AGE OF ONSET; ALLELES; COHORT STUDIES; GENE FREQUENCY; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; HUNTINGTON DISEASE; ISOENZYMES; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 2542481935     PISSN: 14712350     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2350-5-7     Document Type: Article

References (9)

1. Kehoe P, Krawczak M, Harper PS, Owen MJ, Jones AL: Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. J Med Genet 1999, 36:108-111.
2. Li YJ, Oliveira SA, Xu P, Martin ER, Stenger JE, Scherzer CR, Hauser MA, Scott WK, Small GW, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Mastaglia F, Middleton LT, Roses AD, Saunders AM, Schmechel DE, Gullans SR, Haines JL, Gilbert JR, Vance JM, Pericak-Vance MA: Glutathione S-Transferase Omega 1 modifies age-at-onset of Alzheimer Disease and Parkinson Disease. Hum Mol Genet 2003, 24:3259-3267.
3. Warner JP, Barron LH, Brock DJ: A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes 1993, 7:235-239.
4. Brune N, Andrich J, Gencik M, Saft C, Müller T, Valentin S, Przuntek H, Epplen JT: Methyltetrahydrofolate Reductase polymorphism influences onset of Huntington's disease. J Neural Transm in press.
5. Djousse L, Knowlton B, Hayden M, Almqvist EW, Brinkman R, Ross C, Margolis R, Rosenblatt A, Durr A, Dode C, Morrison PJ, Novelletto A, Frontali M, Trent RJ, McCusker E, Gomez-Tortosa E, Mayo D, Jones R, Zanko A, Nance M, Abramson R, Suchowersky O, Paulsen J, Harrison M, Yang Q, Cupples LA, Gusella JF, MacDonald ME, Myers RH: Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease. Am J Med Genet 2003, 3:279-82.
6. Taylor JP, Hardy J, Fischbeck KH: Toxic proteins in neurodegenerative diseases. Science 2002, 296:1991-1995.
7. LaDu MJ, Shah JA, Reardon CA, Getz GS, Bu G, Hu J, Guo L, van Eldik LJ: Apolipoprotein E receptors mediate the effects of beta-amyloid on astrocyte cultures. J Biol Chem 2000, 43:33974-33980.
8. Laliberte RE, Perregaux DG, Hoth LR, Rosner PJ, Jordan CK, Peese KM, Eggler JF, Dombroski MA, Geoghegan KF, Gabel CA: Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing. J Biol Chem 2003, 278:16567-16578.
9. Rubinsztein DC, Leggo J, Chiano M, Dodge A, Norbury G, Rosser E, Craufurd D: Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proc Natl Acad Sci USA 1997, 8:3872-3876.